Tandem Diabetes Care (TNDM) Inventory Average (2014 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Inventory Average came in at $127.6 million in Q1 2026, down 12.25% YoY from $145.4 million in Q1 2025, and down 4.09% on a QoQ basis from $133.0 million in Q4 2025.
Tandem Diabetes Care (TNDM) Inventory Average (2014 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 13 years of Inventory Average data on file, last reported at $127.6 million in Q1 2026.
- Quarterly Inventory Average fell 12.25% year-over-year to $127.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.6 million (down 12.25% YoY) and the FY2025 annual result came in at $139.2 million, down 9.48% from the prior year.
- Inventory Average fell to $127.6 million in Q1 2026, from $133.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $157.8 million in Q2 2024 to a low of $74.3 million in Q1 2022.
- A 5-year average of $131.1 million and a median of $139.9 million in 2025 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average soared 66.08% — and 2026, when it decreased 12.25%.
- Tracing TNDM's Inventory Average over 5 years: stood at $107.9 million in 2022, then soared by 39.62% to $150.7 million in 2023, then climbed by 0.21% to $151.0 million in 2024, then declined by 11.92% to $133.0 million in 2025, then declined by 4.09% to $127.6 million in 2026.
- The last three Inventory Average figures came in at $127.6 million (Q1 2026), $133.0 million (Q4 2025), and $139.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 7.15 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 5.47 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 1.13 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 710.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 2.42 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 3.69 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 671.95 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | 130.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 130.75 Mn |
| Mar 31, 2026 | 127.58 Mn |
| Dec 31, 2025 | 133.03 Mn |
| Sep 30, 2025 | 139.93 Mn |
| Jun 30, 2025 | 141.87 Mn |
| Mar 31, 2025 | 145.39 Mn |
| Dec 31, 2024 | 151.03 Mn |
| Sep 30, 2024 | 157.05 Mn |
| Jun 30, 2024 | 157.78 Mn |
| Mar 31, 2024 | 155.92 Mn |
| Dec 31, 2023 | 150.71 Mn |
| Sep 30, 2023 | 145.55 Mn |
| Jun 30, 2023 | 139.58 Mn |
| Mar 31, 2023 | 121.34 Mn |
| Dec 31, 2022 | 107.95 Mn |
| Sep 30, 2022 | 96.44 Mn |
| Jun 30, 2022 | 84.04 Mn |
| Mar 31, 2022 | 74.27 Mn |
| Dec 31, 2021 | 67.14 Mn |
| Sep 30, 2021 | 66.22 Mn |